116 related articles for article (PubMed ID: 36477590)
1. A Pharmacokinetic Drug-Drug Interactions Study between Entecavir and Hydronidone, a Potential Novel Antifibrotic Small Molecule, in Healthy Male Volunteers.
Zhang R; Li P; Guo P; Zhou J; Wan J; Yang C; Zhou J; Liu Y; Shi S
Adv Ther; 2023 Feb; 40(2):658-670. PubMed ID: 36477590
[TBL] [Abstract][Full Text] [Related]
2. Tolerability and Pharmacokinetics of Hydronidone, an Antifibrotic Agent for Hepatic Fibrosis, after Single and Multiple Doses in Healthy Subjects: an Open-Label, Randomized, Dose-Escalating, First-in-Human Study.
Liu Y; Wu J; Li Z; Luo Y; Zeng F; Shi S
Eur J Drug Metab Pharmacokinet; 2017 Feb; 42(1):37-48. PubMed ID: 26797810
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects.
He X; Liu G; Chen X; Wang Y; Liu R; Wang C; Huang Y; Shen J; Jia Y
Clin Ther; 2023 Jul; 45(7):655-661. PubMed ID: 37451912
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects.
Sun F; Liu Y; Li T; Lin P; Jiang X; Li X; Wang C; Gao X; Ma Y; Fu Y; Cao Y
BMC Pharmacol Toxicol; 2023 Feb; 24(1):7. PubMed ID: 36737825
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic interaction of finasteride with tamsulosin hydrochloride: an open-label, randomized, 3-period crossover study in healthy Chinese male volunteers.
Chu N; Xu H; Wang G; Wang J; Chen W; Yuan F; Yang M; Li X
Clin Ther; 2015 Feb; 37(2):462-72. PubMed ID: 25465944
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic interaction of telmisartan with s-amlodipine: an open-label, two-period crossover study in healthy Korean male volunteers.
Noh YH; Lim HS; Kim MJ; Kim YH; Choi HY; Sung HR; Jin SJ; Lim J; Bae KS
Clin Ther; 2012 Jul; 34(7):1625-35. PubMed ID: 22721873
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects.
Kim CH; Kang SI; Shin D
Adv Ther; 2021 Feb; 38(2):1094-1105. PubMed ID: 33326064
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study.
Li X; Wang C; Li T; Liu Y; Liu S; Tao Y; Ma Y; Gao X; Cao Y
BMC Pharmacol Toxicol; 2020 Nov; 21(1):80. PubMed ID: 33213527
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Interactions and Tolerability of Rosuvastatin and Ezetimibe: A Randomized, Phase 1, Crossover Study in Healthy Chinese Participants.
Wang L; Luan Y; Jia C; Xie X; Zhang Z; Xie X; Wang Q; Hu C; Xie F; Abdel-Moneim M; Hovsepian L; Zhao Z; Yang N; Hou J
Eur J Drug Metab Pharmacokinet; 2023 Jan; 48(1):51-62. PubMed ID: 36437383
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects.
Vaidya SS; Khindri S; Calder N; Machineni S; Hara H; Majumdar T; Febbraro S; Fuhr R; Woessner R
Pulm Pharmacol Ther; 2016 Apr; 37():30-6. PubMed ID: 26845343
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese Volunteers.
Huang Y; Liu R; Wang Y; Liu G; Wang C; Chen X; Jia Y; Shen J
Clin Ther; 2022 Jul; 44(7):945-956. PubMed ID: 35778161
[TBL] [Abstract][Full Text] [Related]
13. Tolerability and pharmacokinetics of ranolazine following single and multiple sustained-release doses in Chinese healthy adult volunteers: a randomized, open-label, Latin square design, phase I study.
Tan QY; Li HD; Zhu RH; Zhang QZ; Zhang J; Peng WX
Am J Cardiovasc Drugs; 2013 Feb; 13(1):17-25. PubMed ID: 23355361
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers.
Lesko LJ; Offman E; Brew CT; Garza D; Benton W; Mayo MR; Romero A; Du Mond C; Weir MR
J Cardiovasc Pharmacol Ther; 2017 Sep; 22(5):434-446. PubMed ID: 28585859
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Interaction Among Ezetimibe, Rosuvastatin, and Telmisartan.
Huh KY; Lee SW; Lee SB; Kim KT; Jang IJ; Lee S
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1290-1296. PubMed ID: 33647189
[TBL] [Abstract][Full Text] [Related]
16. A novel, simple and reliable method for the determination of hydronidone and its metabolites M3 and M4 in human plasma and urine by HPLC-MS/MS and its application to a pharmacokinetic study in health Chinese subjects.
Zhang R; Li P; Zhou J; Guo P; Liu Y; Shi S
Anal Biochem; 2022 Oct; 655():114842. PubMed ID: 35934072
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic Interactions Between Gemigliptin and Metformin, and Potential Differences in the Pharmacokinetic Profile of Gemigliptin Between the Mexican and Korean Populations: A Randomized, Open-label Study in Healthy Mexican Volunteers.
Conde-Carmona I; García-Medina S; Jiménez-Vargas JM; Martínez-Muñoz A; Lee SH
Clin Ther; 2018 Oct; 40(10):1729-1740. PubMed ID: 30249366
[TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability and pharmacokinetics of doravirine, a novel HIV non-nucleoside reverse transcriptase inhibitor, after single and multiple doses in healthy subjects.
Anderson MS; Gilmartin J; Cilissen C; De Lepeleire I; Van Bortel L; Dockendorf MF; Tetteh E; Ancona JK; Liu R; Guo Y; Wagner JA; Butterton JR
Antivir Ther; 2015; 20(4):397-405. PubMed ID: 25470746
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction between rosuvastatin and telmisartan in healthy Korean male volunteers: a randomized, open-label, two-period, crossover, multiple-dose study.
Son M; Kim Y; Lee D; Roh H; Son H; Guk J; Jang SB; Nam SY; Park K
Clin Ther; 2014 Aug; 36(8):1147-58. PubMed ID: 24998012
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects.
Moon SJ; Jeon JY; Jang K; Yu KS; Lim Y; Kim MG
Drug Des Devel Ther; 2019; 13():2533-2542. PubMed ID: 31440035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
